These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7899389)

  • 1. [Mifepristone (RU 486): present status, prospectives].
    Peyron R; Ulmann A; Baulieu EE
    Presse Med; 1995 Feb; 24(6):295-8. PubMed ID: 7899389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [RU 486: current and potential indications. Great expectations and strong resistance].
    Serfaty D
    Presse Med; 1995 Apr; 24(16):775-8. PubMed ID: 7784418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical uses of antiprogestogens.
    Van Look PF; von Hertzen H
    Hum Reprod Update; 1995 Jan; 1(1):19-34. PubMed ID: 9080204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiprogestins and the abortion controversy: a progress report.
    Klitsch M
    Fam Plann Perspect; 1991; 23(6):275-82. PubMed ID: 1786809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
    Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
    N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
    el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
    N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods of second trimester pregnancy termination and evacuation of in utero dead fetuses. Value of mifepristone].
    Maria B; Matheron I
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):642-50. PubMed ID: 7995906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of mifepristone (RU 486) in pregnancy (excluding abortion on demand). The first clinical trials].
    Grall F; Sylvestre L
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(7):987-94. PubMed ID: 1791293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abortion: epidemiology, safety, and technique.
    Blumenthal PD
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):506-12. PubMed ID: 1504270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The fundamental basis and obstetrical applications of mifepristone or RU-486 (voluntary interrupted pregnancies excluded)].
    Winer N; Lopez P; Sagot P; Boog G
    Rev Fr Gynecol Obstet; 1993 Feb; 88(2):73-7. PubMed ID: 8469867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of RU-486 (mifepristone) in medical indications of the induction of labor at term. Results of a double-blind randomized prospective study (RU-486 versus placebo)].
    Lelaidier C; Benifla JL; Fernandez H; Baton C; Bourget P; Bourrier MC; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):91-100. PubMed ID: 8463575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone (RU 486) in the United States. What does the future hold?
    Rosenfield A
    N Engl J Med; 1993 May; 328(21):1560-1. PubMed ID: 8479494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined use of prostaglandin and antiprogestin in human fertility control.
    Baulieu EE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():55-62. PubMed ID: 7732905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprogesterones.
    Norman J
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
    Brogden RN; Goa KL; Faulds D
    Drugs; 1993 Mar; 45(3):384-409. PubMed ID: 7682909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone and misoprostol sequential regimen side effects, complications and safety.
    Sitruk-Ware R
    Contraception; 2006 Jul; 74(1):48-55. PubMed ID: 16781261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical termination of pregnancy with mifepristone--initial experience at the Sheba Medical Center].
    Machtinger R; Goldenberg M; Soriano D; Zolti M; Atlas M; Seidman DS
    Harefuah; 2003 Oct; 142(10):666-8, 719. PubMed ID: 14565062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological study of uterine cervix during termination of early pregnancy by mifepristone and prostaglandins].
    Weng L; Jiao L; Tang X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):522-5. PubMed ID: 8556909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mifepristone (RU 486)].
    Bonelli RM
    Diskussionsforum Med Ethik; 1992; (6-7):XXXVIII-XLIII. PubMed ID: 1514299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.